The Aβ-clearance protein transthyretin, like neprilysin, is epigenetically regulated by the amyloid precursor protein intracellular domain

Journal of Neurochemistry

Volumn 130, Issue 3, 2014, Pages 419-431

  Kerridge, Caroline ^a,c   Belyaev, Nikolai D ^a   Nalivaeva, Natalia N ^a,b   Turner, Anthony J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b SECHENOV INSTITUTE OF EVOLUTIONARY PHYSIOLOGY AND BIOCHEMISTRY   (Russian Federation)

^c Neurodegeneration DHT Lilly Erl Wood Manor ^*  (United Kingdom)

Author keywords

Alzheimer's disease; amyloid precursor protein intracellular domain; Gleevec; neprilysin; transthyretin

Indexed keywords

AMMONIUM CHLORIDE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; AMYLOID PRECURSOR PROTEIN ISOFORM 695; AMYLOID PRECURSOR PROTEIN ISOFORM 751; AMYLOID PRECURSOR PROTEIN ISOFORM 770; AQUAPORIN 1; GAMMA SECRETASE; GLYCOGEN SYNTHASE KINASE 3BETA; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 3; IMATINIB; ISOPROTEIN; KLOTHO PROTEIN; MEMBRANE METALLOENDOPEPTIDASE; PREALBUMIN; UNCLASSIFIED DRUG; VALPROIC ACID;

ALKALINIZATION; ALZHEIMER DISEASE; AMYLOID PRECURSOR PROTEIN INTRACELLULAR DOMAIN; AQP1 GENE; ARTICLE; BIOACCUMULATION; CELL LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME REGULATION; EPIGENETICS; GENE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC REGULATION; GSK 3BETA GENE; HUMAN; HUMAN CELL; KLOTHO GENE; NEP GENE; NEUROBLASTOMA CELL LINE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN CLEAVAGE; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TTR GENE; UPREGULATION;

ALZHEIMER'S DISEASE; AMYLOID PRECURSOR PROTEIN INTRACELLULAR DOMAIN; GLEEVEC; NEPRILYSIN; TRANSTHYRETIN;

AMMONIUM CHLORIDE; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; BENZAMIDES; BLOTTING, WESTERN; CHROMATIN IMMUNOPRECIPITATION; CYTIDINE DEAMINASE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EPIGENESIS, GENETIC; GENE EXPRESSION; HISTONE DEACETYLASE 1; HISTONE DEACETYLASES; HUMANS; IMMUNOHISTOCHEMISTRY; NEPRILYSIN; PIPERAZINES; PREALBUMIN; PYRIMIDINES;

EID: 84904631001     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12680     Document Type: Article

References (71)

1. Asai M., Yagishita S., Iwata N., Saido T. C., Ishiura S., and, Maruyama K., (2011) An alternative metabolic pathway of amyloid precursor protein C-terminal fragments via cathepsin B in a human neuroglioma model. FASEB J. 10, 3720-3730.
2. Bauer C., Pardossi-Piquard R., Dunys J., Roy M., and, Checler F., (2011) γ-Secretase-Mediated Regulation of Neprilysin: Influence of Cell Density and Aging and Modulation by Imatinib. J. Alzheimers Dis. 27, 511-520.
3. Beckett C., Nalivaeva N. N., Belyaev N. D., and, Turner A. J., (2012) Nuclear signalling by membrane protein intracellular domains: the AICD enigma. Cell. Signal. 24, 402-409.
4. Belyaev N. D., Nalivaeva N. N., Makova N. Z., and, Turner A. J., (2009) Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease. EMBO Rep. 10, 94-100.
5. Belyaev N. D., Kellett K. A., Beckett C., Makova N. Z., Revett T. J., Nalivaeva N. N., Hooper N. M., and, Turner A. J., (2010) The transcriptionally active amyloid precursor protein (APP) intracellular domain is preferentially produced from the 695 isoform of APP in a β-secretase-dependent pathway. J. Biol. Chem. 285, 41443-41454.
6. Bertrand E., Brouillet E., Caillé I., Bouillot C., Cole G. M., Prochiantz A., and, Allinquant B., (2001) A short cytoplasmic domain of the amyloid precursor protein induces apoptosis in vitro and in vivo. Mol. Cell. Neurosci. 18, 503-511.
7. Brouillette J., Caillierez R., Zommer N., Alves-Pires C., Benilova I., Blum D., De Strooper B., and, Buée L., (2012) Neurotoxicity and memory deficits induced by soluble low-molecular-weight amyloid-β1-42 oligomers are revealed in vivo by using a novel animal model. J. Neurosci. 32, 7852-7861.
8. Buxbaum J. N., Ye Z., Reixach N., Friske L., Levy C., Das P., Golde T., Masliah E., Roberts A. R., and, Bartfai T., (2008) Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Aβ toxicity. Proc. Natl Acad. Sci. USA 105, 2681-2686.
9. Cao X., and, Südhof T. C., (2001) A transcriptively active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293, 115-120.
10. Carraro-Lacroix L. R., Jaumouillé V., Fairn G. D., and, Grinstein S., (2011) A weak base-generating system suitable for selective manipulation of lysosomal pH. Traffic 12, 1490-1500.
11. Chakrabarti A., Chatterjee A., Sengupta M.B., Chattopadhyay P., and, Mukhopadhyay D., (2013) Altered levels of amyloid precursor protein intracellular domain-interacting proteins in Alzheimer disease. Alzheimer Dis. Assoc. Disord. [Epub ahead of print]
12. Cupers P., Orlans I., Craessaerts K., Annaert W., and, De Strooper B., (2001) The amyloid precursor protein (APP)-cytoplasmic fragment generated by γ-secretase is rapidly degraded but distributes partially in a nuclear fraction of neurones in culture. J. Neurochem. 78, 1168-1178.
13. Dovey O. M., Foster C. T., and, Cowley S. M., (2010) Histone deacetylase 1 (HDAC1), but not HDAC2, controls embryonic stem cell differentiation. Proc. Natl Acad. Sci. USA 107, 8242-8247.
14. Du J., Cho P. Y., Yang D. T., and, Murphy R. M., (2012) Identification of β-amyloid-binding sites on transthyretin. Protein Eng. Des. Sel. 25, 337-345.
15. Edbauer D., Willem M., Lammich S., Steiner H., and, Haass C., (2002) Insulin-degrading enzyme rapidly removes the β-amyloid precursor protein intracellular domain (AICD). J. Biol. Chem. 277, 13389-13393.
16. Eisele Y. S., Baumann M., Klebl B., Nordhammer C., Jucker M., and, Kilger E., (2007) Gleevec increases levels of the amyloid precursor protein intracellular domain and of the amyloid-β degrading enzyme neprilysin. Mol. Biol. Cell 18, 3591-3600.
17. Fraering P. C., Ye W., LaVoie M. J., Ostaszewski B. L., Selkoe D. J., and, Wolfe M. S., (2005) γ-Secretase substrate selectivity can be modulated directly via interaction with a nucleotide-binding site. J. Biol. Chem. 280, 41987-41996.
18. Ghosal K., Vogt D. L., Liang M., Shen Y., Lamb B. T., and, Pimplikar S. W., (2009) Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain. Proc. Natl Acad. Sci. USA 106, 18367-18372.
19. Glenner G. G., and, Wong C. W., (1984) Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885-890.
20. Goate A., and, Hardy J., (2012) Twenty years of Alzheimer's disease-causing mutations. J. Neurochem. 120 (Suppl 1), 3-8.
21. Gordon A. H., Hart P. D., and, Young M. R., (1980) Ammonia inhibits phagosome-lysosome fusion in macrophages. Nature 286, 79-80.
22. Gregory G. C., and, Halliday G. M., (2005) What is the dominant Aβ species in human brain tissue? A review. Neurotox. Res. 7, 29-41.
23. Grimm M. O., Zinser E. G., Grösgen S., et al,. (2012) Amyloid precursor protein (APP) mediated regulation of ganglioside homeostasis linking Alzheimer's disease pathology with ganglioside metabolism. PLoS ONE 7, e34095.
24. Hansson S. F., Andréasson U., Wall M., Skoog I., Andreasen N., Wallin N. A., Zetterberg H., and, Blennow K., (2009) Reduced levels of amyloid-β-binding proteins in cerebrospinal fluid from Alzheimer's disease patients. J. Alzheimers Dis. 16, 389-397.
25. Hardy J., (2009) The amyloid hypothesis for Alzheimer's disease: a critical reappraisal. J. Neurochem. 110, 1129-1134.
26. Hardy J. A., and, Higgins G. A., (1992) Alzheimer's disease: the amyloid cascade hypothesis. Science 256, 184-185.
27. Hicks D. A., Makova N. Z., Gough M., Parkin E. T., Nalivaeva N. N., and, Turner A. J., (2013) The amyloid precursor protein represses expression of acetylcholinesterase in neuronal cell lines. J. Biol. Chem. 288, 26039-26051.
28. Hong Y., Beckett C., Belyaev N. D., and, Turner A. J., (2011) The impact of amyloid precursor protein signalling and histone deacetylase inhibition on neprilysin expression in human prostate cells. Int. J. Cancer 130, 775-786.
29. Huysseune S., Kienlen-Campard P., Hébert S., Tasiaux B., Leroy K., Devuyst O., Brion J. P., De Strooper B., and, Octave J. N., (2009) Epigenetic control of aquaporin 1 expression by the amyloid precursor protein. FASEB J. 23, 4158-4167.
30. Iwata N., Takaki Y., Fukami S., Tsubuki S., and, Saido T. C., (2002) Region-specific reduction of A β-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging. J. Neurosci. Res. 70, 493-500.
31. Jonsson T., Atwal J. K., Steinberg S., et al,. (2012) A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature 488, 96-99.
32. Kim H. S., Kim E. M., Lee J. P., et al,. (2003) C-terminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3β expression. FASEB J. 17, 1951-1953.
33. Koh Y. H., von Arnim C. A., Hyman B. T., Tanzi R. E., and, Tesco G., (2005) BACE is degraded via the lysosomal pathway. J. Biol. Chem. 280, 32499-32504.
34. Leissring M. A., (2008) The AβCs of Aβ-cleaving proteases. J. Biol. Chem. 283, 29645-29649.
35. Li H., Wang B., Wang Z., Guo Q., Tabuchi K., Hammer R. E., Südhof T. C., and, Zheng H., (2010) Soluble amyloid precursor protein (APP) regulates transthyretin and Klotho gene expression without rescuing the essential function of APP. Proc. Natl Acad. Sci. USA 107, 17362-17367.
36. Li X., Masliah E., Reixach N., and, Buxbaum J. N., (2011) Neuronal production of transthyretin in human and murine Alzheimer's disease: is it protective? J. Neurosci. 31, 12483-12490.
37. Marambaud P., and, Robakis N. K., (2005) Genetic and molecular aspects of Alzheimer's disease shed light on new mechanisms of transcriptional regulation. Genes Brain. Behav. 4, 134-146.
38. Müller T., Concannon C. G., Ward M. W., Walsh C. M., Tirniceriu A. L., Tribl F., Kögel D., Prehn J. H., and, Egensperger R., (2007) Modulation of gene expression and cytoskeletal dynamics by the amyloid precursor protein intracellular domain (AICD). Mol. Biol. Cell 18, 201-210.
39. Müller T., Loosse C., Schrötter A., Schnabel A., Helling S., Egensperger R., and, Marcus K., (2011) The AICD interacting protein DAB1 is up-regulated in Alzheimer frontal cortex brain samples and causes deregulation of proteins involved in gene expression changes. Curr. Alzheimer Res. 8, 573-582.
40. Nalivaeva N. N., and, Turner A. J., (2013) The amyloid precursor protein: a biochemical enigma in brain development, function and disease. FEBS Lett. 587, 2046-2054.
41. Nalivaeva N. N., Beckett C., Belyaev N. D., and, Turner A. J., (2012a) Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer's disease? J. Neurochem. 120 (Suppl 1), 167-185.
42. Nalivaeva N. N., Belyaev N. D., Lewis D. I., Pickles A. R., Makova N. Z., Bagrova D. I., Dubrovskaya N. M., Plesneva S. A., Zhuravin I. A., and, Turner A. J., (2012b) Effect of sodium valproate administration on brain neprilysin expression and memory in rats. J. Mol. Neurosci. 46, 569-577.
43. Netzer W. J., Dou F., Cai D., Veach D., Jean S., Li Y., Bornmann W. G., Clarkson B., Xu H., and, Greengard P., (2003) Gleevec inhibits β-amyloid production but not Notch cleavage. Proc. Natl Acad. Sci. USA 100, 12444-12449.
44. Nunan J., Shearman M. S., Checler F., Cappai R., Evin G., Beyreuther K., Masters C. L., and, Small D. H., (2001) The C-terminal fragment of the Alzheimer's disease amyloid protein precursor is degraded by a proteasome-dependent mechanism distinct from γ-secretase. Eur. J. Biochem. 268, 5329-5336.
45. Octave J. N., Pierrot N., Ferao Santos S., Nalivaeva N. N., and, Turner A. J., (2013) From synaptic spines to nuclear signaling: nuclear and synaptic actions of the amyloid precursor protein. J. Neurochem. 126, 183-190.
46. Pardossi-Piquard R., and, Checler F., (2012) The physiology of the β-amyloid precursor protein intracellular domain AICD. J. Neurochem. 120 (Suppl 1), 109-124.
47. Pardossi-Piquard R., Petit A., Kawarai T., et al,. (2005) Presenilin-dependent transcriptional control of the Aβ-degrading enzyme neprilysin by intracellular domains of βAPP and APLP. Neuron 46, 541-554.
48. Passer B., Pellegrini L., Russo C., Siegel R. M., Lenardio M. J., Schettini G., Bachmann M., Tabaton M., and, D'Adamio L., (2000) Generation of an apoptotic intracellular peptide by γ-secretase cleavage of Alzheimer's amyloid β protein precursor. J. Alzheimer's Dis. 2, 289-301.
49. Pelzel H. R., Schlamp C. L., and, Nickells R. W., (2010) Histone H4 deacetylation plays a critical role in early gene silencing during neuronal apoptosis. BMC Neurosci. 11, 62.
50. Pierrot N., Tyteca D., D'auria L., et al,. (2013) Amyloid precursor protein controls cholesterol turnover needed for neuronal activity. EMBO Mol. Med. 5, 608-625.
51. Pimplikar S. W., Nixon R. A., Robakis N. K., Shen J., and, Tsai L. H., (2010) Amyloid-independent mechanisms in Alzheimer's disease pathogenesis. J. Neurosci. 30, 14946-14954.
52. Relton J. M., Gee N. S., Matsas R., Turner A. J., and, Kenny A. J., (1983) Purification of endopeptidase-24.11 ('enkephalinase') from pig brain by immunoadsorbent chromatography. Biochem. J. 215, 519-523.
53. von Rotz R. C., Kohli B. M., Bosset J., Meier M., Suzuki T., Nitsch R. M., and, Konietzko U., (2004) The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor. J. Cell Sci. 117, 4435-4448.
54. Ryan K. A., and, Pimplikar S. W., (2005) Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain. J. Cell Biol. 171, 327-335.
55. Saido T., and, Leissring M. A., (2012) Proteolytic degradation of amyloid β-protein. Cold Spring Harb. Perspect. Med. 2, a006379.
56. Schwarzman A. L., Gregoti L., Vitek M. P., et al,. (1994) Transthyretin sequesters amyloid β protein and prevents amyloid formation. Proc. Natl Acad. Sci. USA 91, 8368-8372.
57. Selkoe D. J., (2012) Preventing Alzheimer's disease. Science 337, 1488-1492.
58. Selkoe D., and, Kopan R., (2003) Notch and Presenilin: regulated intramembrane proteolysis links development and degeneration. Annu. Rev. Neurosci. 26, 565-597.
59. Shirotani K., Tsubuki S., Iwata N., et al,. (2001) Neprilysin degrades both amyloid β peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases. J. Biol. Chem. 276, 21895-21901.
60. Sousa J. C., Cardoso I., Marques F., Saraiva M. J., and, Palha J. A., (2006) Transthyretin and Alzheimer's disease: where in the brain? Neurobiol. Aging 28, 713-718.
61. Stein T. D., and, Johnson J. A., (2002) Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways. J. Neurosci. 22, 7380-7388.
62. Tsuzuki K., Fukatsu R., Yamaguchi H., Tateno M., Imai K., Fujii N., and, Yamauchi T., (2000) Transthyretin binds amyloid β peptides, Aβ1-42 and Aβ1-40 to form complex in the autopsied human kidney-possible role of transthyretin for aβ sequestration. Neurosci. Lett. 281, 171-1714.
63. Vázquez M. C., Vargas L. M., Inestrosa N. C., and, Alvarez A. R., (2009) c-Abl modulates AICD dependent cellular responses: Transcriptional induction and apoptosis. J. Cell. Physiol. 220, 136-143.
64. Vingtdeux V., Hamdane M., Begard S., Loyens A., Delacourte A., Beauvillain J. C., Buée L., Marambaud P., and, Sergeant N., (2007a) Intracellular pH regulates amyloid precursor protein intracellular domain accumulation. Neurobiol. Dis. 25, 686-696.
65. Vingtdeux V., Hamdane M., Loyens A., et al,. (2007b) Alkalizing drugs induce accumulation of amyloid precursor protein by-products in luminal vesicles of multivesicular bodies. J. Biol. Chem. 282, 18197-18205.
66. Walsh D. M., Klyubin I., Fadeeva J. V., Cullen W. K., Anwyl R., Wolfe M. S., Rowan M. J., and, Selkoe D. J., (2002) Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539.
67. Weidemann A., Eggert S., Reinhard F. B., Vogel M., Paliga K., Baier G., Masters C. L., Beyreuther K., and, Evin G., (2002) A novel ε-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with Notch processing. Biochemistry 41, 2825-2835.
68. Yamada T., Sasaki H., Dohura K., Goto I., and, Sakaki Y., (1989) Structure and expression of the alternatively-spliced forms of mRNA for the mouse homolog of Alzheimer's disease amyloid beta protein precursor. Biochem. Biophys. Res. Commun. 158, 906-912.
69. Yasojima K., McGeer E. G., and, McGeer P. L., (2001) Relationship between β amyloid peptide generating molecules and neprilysin in Alzheimer disease and normal brain. Brain Res. 919, 115-121.
70. Zhou F., Gong K., Song B., Ma T., van Laar T., Gong Y., and, Zhang L., (2012) The APP intracellular domain (AICD) inhibits Wnt signalling and promotes neurite outgrowth. Biochim. Biophys. Acta 1823, 1233-1241.
71. Zuccato C., Belyaev N., Conforti P., et al,. (2007) Widespread disruption of repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease. J. Neurosci. 27, 6972-6983.